================================================================
Interpretable Rule-Based Prediction of Cisplatin Response
in Lung Cancer using R.ROSETTA
================================================================

DATA SOURCE: GDSC2 (Genomics of Drug Sensitivity in Cancer)
TISSUE: Lung Cancer
DRUG: Cisplatin
SAMPLES: 127 (Sensitive=64, Resistant=63)
FEATURES: 43 genes
FEATURE SELECTION: LASSO (34 genes) + Boruta (11 genes) = 43 union

MODEL PERFORMANCE:
  Accuracy Mean: 0.739231 
  Accuracy Median: 0.734615 
  Accuracy SD: 0.082247 
  Accuracy Range: 0.615385 - 0.923077 
  Permutation p-value: 0 (n=100)

TOTAL RULES: 241 

TOP 10 HUB GENES:

   TUFT1  SERINC3 C16orf58     EGFR   KIF21B    SSBP1 
      35       30       22       21       21       21 
   INTS6  PRPF40A  PCOLCE2     SGCE 
      20       20       19       19 

KEY FINDINGS:
- EGFR appears in 21 resistance rules (validated target)
- SLFN11 appears in sensitivity rules (known cisplatin biomarker)
- MSH2 (DNA repair) in sensitivity rules (biologically plausible)
- TUFT1 is the top hub gene (35 rules) - potential novel biomarker
